See more : Hybrid Kinetic Group Limited (FESTF) Income Statement Analysis – Financial Results
Complete financial analysis of HCA Healthcare, Inc. (HCA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HCA Healthcare, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Pantheon Infrastructure PLC (PINT.L) Income Statement Analysis – Financial Results
- Mongolia Growth Group Ltd. (YAK.V) Income Statement Analysis – Financial Results
- Cargojet Inc. (CGJTF) Income Statement Analysis – Financial Results
- United American Healthcare Corporation (UAHC) Income Statement Analysis – Financial Results
- Incap Limited (INCAP.BO) Income Statement Analysis – Financial Results
HCA Healthcare, Inc. (HCA)
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 64.97B | 60.23B | 58.75B | 51.53B | 51.34B | 46.68B | 43.61B | 41.49B | 39.68B | 36.92B | 34.18B | 33.01B | 32.51B | 30.68B | 30.05B | 28.37B | 26.86B | 25.48B | 24.46B | 23.50B | 21.81B | 19.73B | 17.95B | 16.67B | 16.66B | 18.68B | 18.82B | 19.91B | 17.70B | 11.13B | 10.25B | 761.60M | 461.00M | 272.60M |
| Cost of Revenue | 55.34B | 9.37B | 9.48B | 8.37B | 8.48B | 7.72B | 7.32B | 6.93B | 6.64B | 6.26B | 5.97B | 5.72B | 5.18B | 4.96B | 16.83B | 4.62B | 4.40B | 4.32B | 4.13B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.51B | 230.50M | 135.30M | 81.30M |
| Gross Profit | 9.63B | 50.86B | 49.27B | 43.16B | 42.86B | 38.95B | 36.30B | 34.56B | 33.04B | 30.66B | 28.21B | 27.30B | 27.33B | 25.72B | 13.23B | 23.75B | 22.46B | 21.16B | 20.33B | 23.50B | 21.81B | 19.73B | 17.95B | 16.67B | 16.66B | 18.68B | 18.82B | 19.91B | 17.70B | 11.13B | 6.74B | 531.10M | 325.70M | 191.30M |
| Gross Profit Ratio | 14.82% | 84.44% | 83.86% | 83.76% | 83.48% | 83.45% | 83.23% | 83.29% | 83.27% | 83.04% | 82.53% | 82.68% | 84.07% | 83.83% | 44.01% | 83.72% | 83.64% | 83.04% | 83.13% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 65.74% | 69.73% | 70.65% | 70.18% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 29.49B | 27.69B | 26.78B | 23.87B | 23.56B | 21.43B | 20.06B | 18.90B | 18.12B | 16.64B | 15.65B | 15.09B | 13.44B | 12.48B | 11.96B | 11.44B | 10.71B | 10.41B | 9.93B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 29.49B | 27.69B | 26.78B | 23.87B | 23.56B | 21.43B | 20.06B | 18.90B | 18.12B | 16.64B | 15.65B | 15.09B | 13.44B | 12.48B | 11.96B | 11.44B | 10.71B | 10.41B | 9.93B | 9.42B | 8.68B | 7.95B | 7.28B | 6.64B | 6.75B | 7.81B | 7.63B | 7.84B | 7.10B | 0.00 | 4.76B | 452.00M | 283.40M | 162.20M |
| Other Expenses | 0.00 | 14.12B | 12.81B | 12.03B | 12.08B | 10.89B | -466.00M | -430.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 45.44B | 41.81B | 39.59B | 35.90B | 35.64B | 32.31B | 30.24B | 28.36B | 27.08B | 25.09B | 23.42B | 22.48B | 22.99B | 21.56B | 9.19B | 20.82B | 19.31B | 18.08B | 17.43B | 20.80B | 19.01B | 17.68B | 15.73B | 15.45B | 14.79B | 16.86B | 17.65B | 16.76B | 15.34B | 9.62B | 5.36B | 490.30M | 305.90M | 174.10M |
| Cost & Expenses | 55.34B | 51.18B | 49.07B | 44.27B | 44.12B | 40.04B | 37.56B | 35.29B | 33.71B | 31.35B | 29.39B | 28.20B | 28.17B | 26.52B | 26.02B | 25.44B | 23.70B | 22.40B | 21.55B | 20.80B | 19.01B | 17.68B | 15.73B | 15.45B | 14.79B | 16.86B | 17.65B | 16.76B | 15.34B | 9.62B | 8.87B | 720.80M | 441.20M | 255.40M |
| Interest Income | 0.00 | 1.74B | 1.57B | 1.58B | 1.82B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.94B | 1.74B | 1.57B | 1.58B | 1.82B | 1.76B | 1.69B | 1.71B | 1.67B | 1.74B | 1.85B | 1.80B | 2.04B | 2.10B | 1.99B | 2.02B | 2.22B | 955.00M | 655.00M | 563.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 3.08B | 2.97B | 2.85B | 2.72B | 2.60B | 2.28B | 2.13B | 1.97B | 1.90B | 1.82B | 1.75B | 1.68B | 1.47B | 1.42B | 1.43B | 1.42B | 1.43B | 1.39B | 1.37B | 1.25B | 1.11B | 1.01B | 1.05B | 1.03B | 1.09B | 1.25B | 1.24B | 1.16B | 981.00M | 609.00M | -599.00M | -38.30M | -22.50M | -11.90M |
| EBITDA | 12.72B | 13.29B | 14.25B | 9.74B | 9.66B | 9.37B | 8.20B | 8.48B | 7.53B | 7.04B | 6.55B | 6.37B | 7.06B | 5.75B | 5.07B | 4.61B | 4.83B | 4.21B | 4.36B | 3.95B | 4.04B | 3.08B | 3.29B | 2.43B | 3.30B | 18.68B | 2.85B | 4.31B | 3.33B | 2.12B | 2.07B | 21.40M | 3.90M | 11.40M |
| EBITDA Ratio | 19.58% | 20.03% | 21.52% | 19.48% | 19.20% | 19.17% | 18.88% | 19.81% | 19.95% | 20.12% | 19.23% | 19.78% | 18.65% | 19.12% | 18.16% | 14.51% | 17.07% | 17.54% | 16.04% | 16.88% | 18.52% | 15.60% | 18.69% | 14.60% | 19.82% | 19.93% | 15.89% | 21.64% | 18.84% | 19.02% | 20.17% | 2.81% | 0.85% | 4.18% |
| Operating Income | 9.63B | 9.10B | 9.79B | 7.32B | 7.26B | 6.64B | 6.10B | 6.25B | 6.01B | 5.61B | 4.82B | 4.85B | 4.60B | 4.45B | 4.03B | 2.70B | 3.16B | 3.08B | 2.55B | 2.72B | 2.93B | 2.07B | 2.31B | 1.40B | 2.21B | 2.48B | 1.75B | 3.15B | 2.35B | 1.51B | 2.67B | 59.70M | 26.40M | 23.30M |
| Operating Income Ratio | 14.82% | 15.10% | 16.66% | 14.20% | 14.14% | 14.23% | 13.99% | 15.07% | 15.15% | 15.19% | 14.10% | 14.70% | 14.14% | 14.49% | 13.42% | 9.52% | 11.76% | 12.08% | 10.42% | 11.56% | 13.42% | 10.48% | 12.85% | 8.40% | 13.25% | 13.25% | 9.32% | 15.84% | 13.29% | 13.55% | 26.01% | 7.84% | 5.73% | 8.55% |
| Total Other Income/Expenses | -1.92B | -473.00M | 155.00M | -1.83B | -1.97B | -1.31B | -1.68B | -1.39B | -1.96B | -1.96B | -1.62B | -1.92B | -777.00M | -1.93B | -1.80B | -1.77B | -1.76B | -974.00M | -577.00M | -743.00M | -771.00M | -594.00M | -720.00M | -16.04B | -15.21B | -15.81B | -783.00M | -456.00M | -930.00M | -277.00M | -415.00M | 1.90M | 5.20M | -3.70M |
| Income Before Tax | 7.71B | 8.58B | 9.83B | 5.43B | 5.24B | 5.34B | 4.38B | 4.81B | 3.96B | 3.48B | 2.95B | 2.89B | 3.56B | 2.23B | 2.00B | 941.00M | 1.19B | 1.66B | 2.15B | 1.97B | 2.16B | 1.46B | 1.51B | 516.00M | 1.23B | 1.08B | 388.00M | 2.52B | 1.78B | 1.23B | 969.00M | 42.70M | 25.00M | 13.50M |
| Income Before Tax Ratio | 11.86% | 14.24% | 16.74% | 10.54% | 10.22% | 11.43% | 10.04% | 11.59% | 9.97% | 9.43% | 8.62% | 8.77% | 10.95% | 7.27% | 6.66% | 3.32% | 4.43% | 6.52% | 8.79% | 8.40% | 9.89% | 7.37% | 8.38% | 3.10% | 7.37% | 5.79% | 2.06% | 12.63% | 10.05% | 11.06% | 9.45% | 5.61% | 5.42% | 4.95% |
| Income Tax Expense | 1.62B | 1.75B | 2.11B | 1.04B | 1.10B | 946.00M | 1.64B | 1.38B | 1.26B | 1.11B | 950.00M | 888.00M | 719.00M | 658.00M | 627.00M | 268.00M | 316.00M | 625.00M | 725.00M | 727.00M | 824.00M | 622.00M | 602.00M | 297.00M | 570.00M | 549.00M | 206.00M | 1.01B | 715.00M | 486.00M | 394.00M | 16.80M | 9.80M | 3.70M |
| Net Income | 5.24B | 5.64B | 6.96B | 3.75B | 3.51B | 3.79B | 2.22B | 2.89B | 2.13B | 1.88B | 1.56B | 1.61B | 2.47B | 1.21B | 1.05B | 673.00M | 874.00M | 1.04B | 1.42B | 1.25B | 1.33B | 833.00M | 886.00M | 219.00M | 657.00M | 379.00M | -305.00M | 1.51B | 961.00M | 630.00M | 507.00M | 25.50M | 15.20M | 9.80M |
| Net Income Ratio | 8.07% | 9.37% | 11.84% | 7.28% | 6.83% | 8.11% | 5.08% | 6.97% | 5.37% | 5.08% | 4.55% | 4.86% | 7.58% | 3.93% | 3.51% | 2.37% | 3.25% | 4.07% | 5.82% | 5.30% | 6.11% | 4.22% | 4.94% | 1.31% | 3.94% | 2.03% | -1.62% | 7.56% | 5.43% | 5.66% | 4.95% | 3.35% | 3.30% | 3.60% |
| EPS | 19.24 | 19.44 | 21.51 | 11.10 | 10.27 | 11.04 | 6.33 | 7.80 | 5.34 | 4.46 | 3.54 | 3.62 | 5.17 | 2.83 | 3.08 | 1.97 | 2.56 | 2.57 | 3.24 | 2.62 | 2.66 | 1.63 | 1.69 | 0.39 | 1.12 | 0.73 | -0.46 | 2.24 | 1.44 | 1.80 | 1.05 | 0.78 | 0.61 | 0.55 |
| EPS Diluted | 18.96 | 19.15 | 21.16 | 10.93 | 10.07 | 10.66 | 5.95 | 7.30 | 4.99 | 4.16 | 3.37 | 3.49 | 4.97 | 2.76 | 3.02 | 1.93 | 2.51 | 2.53 | 3.18 | 2.58 | 2.61 | 1.59 | 1.65 | 0.39 | 1.11 | 0.73 | -0.46 | 2.22 | 1.43 | 1.80 | 1.03 | 0.78 | 0.61 | 0.55 |
| Weighted Avg Shares Out | 272.40M | 290.35M | 323.32M | 338.27M | 341.21M | 342.90M | 350.09M | 370.54M | 398.74M | 420.48M | 439.60M | 443.20M | 476.61M | 426.42M | 341.93M | 341.93M | 341.93M | 403.40M | 440.02M | 475.62M | 500.75M | 511.04M | 524.26M | 748.72M | 660.71M | 645.21M | 663.04M | 671.88M | 667.36M | 350.00M | 482.86M | 32.69M | 24.92M | 17.82M |
| Weighted Avg Shares Out (Dil) | 276.41M | 294.67M | 328.75M | 343.61M | 348.23M | 355.30M | 372.22M | 395.85M | 426.72M | 450.35M | 461.91M | 459.40M | 495.94M | 437.35M | 348.71M | 348.71M | 348.71M | 410.21M | 447.50M | 483.66M | 510.34M | 523.90M | 536.97M | 748.72M | 666.67M | 645.21M | 663.04M | 677.93M | 672.03M | 516.67M | 492.23M | 32.69M | 24.92M | 17.82M |
Commure To Partner with HCA Healthcare on Ambient AI Platform
MOUNTAIN VIEW, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Commure has been selected by HCA Healthcare, Inc., one of the nation's leading providers of healthcare services, as the exclusive partner to develop and deploy an ambient AI platform across its...
HCA Healthcare Pre-Q3 Earnings: Healthy Buy or a Diagnosis to Wait?
HCA's third-quarter earnings are likely to benefit from improved admissions, capacity additions and payer mix, partially offset by rising operating expenses.
Insights Into HCA (HCA) Q3: Wall Street Projections for Key Metrics
Evaluate the expected performance of HCA (HCA) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
HCA Healthcare Q3 Earnings Preview: Step Change In Value (Rating Upgrade)
I previously rated HCA Healthcare a hold due to flat DCF price target of $319 and mixed industry trends. Since my last analysis, industry cost pressures have eased while healthcare spending continues to grow. With additional upside potential and risks...
Prediction: These 2 Stocks Will Beat the S&P 500 Through 2030
There's no need to change a winning formula.
HCA Healthcare (HCA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare, Inc. to Present at November Healthcare Conferences
NASHVILLE--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA), is scheduled to present at the following healthcare conferences: November 14, 2024 at 7:15am PT at the 2024 UBS Global Healthcare Conference at the Terranea Resort in Ranchos Palos Verdes, CA. November 20, 2024...
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
General Medical and Surgical Hospitals Industry Report, 2024: Analysis by Service Type, Hospital Type, and Service Area (2020-2030) Featuring Profiles of Key Players - HCA Healthcare, Apollo Hospitals & More
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "General Medical and Surgical Hospitals Market (2024 Edition): Analysis by Service Type, Hospital Type, Service Area, and Region: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering. This report...
Will HCA (HCA) Beat Estimates Again in Its Next Earnings Report?
HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Source: https://incomestatements.info
Category: Stock Reports